Live news related to VALNEVA stock (FR0004056851): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
Valneva sees a notable increase this Thursday, March 5, with shares trading at 4.794 euros mid-session, up 2.3% from the previous day's close. This ri…
Goldman Sachs ajuste sa position sur Valneva ce vendredi 27 février 2026.
Valneva's stock fell by 2.26% this Thursday morning to €4.754, after closing at €4.86 the previous day. This corrective movement occurs in a context o…
Valneva has risen by 0.92% this Friday morning to 4.63 euros, following the announcement of its annual 2025 revenue. The stock has shown a sustained u…
Valneva's stock saw a significant increase this Thursday, driven by the release of its preliminary results for the fiscal year 2025. The stock rose by…
The biopharmaceutical group Valneva has released its preliminary results for 2025, marked by stable revenue and strengthened cash reserves. The year 2…
Goldman Sachs ajuste sa position sur Valneva ce jeudi 5 février 2026.
Valneva's stock recorded a 3.13% increase at midday on Wednesday, February 4, 2026, reaching 4.026 euros. The biotech company, specializing in vaccine…
Valneva SE and the Instituto Butantan announce the initiation of a pilot vaccination campaign in Brazil using IXCHIQ®, a single-dose vaccine against c…
Valneva, a French vaccine specialist, closed the week at 3.89 euros, marking a decline of 11.35%. This correction follows an annual increase of 64.61%…
